Tom Frohlich, Chief Operating Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 10,000 shares at $25.00 ($250K) on 2022-12-13, disclosed to the SEC on 2022-12-15.
Open-market sale of $250k KDNY by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KDNY | SELL | 2023-02-02 | $225K | — | Filing → |
| KDNY | SELL | 2022-11-09 | $222K | — | Filing → |
| KDNY | SELL | 2022-10-11 | $290K | — | Filing → |